3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
23
Unknown
15
Recruiting
12
Terminated
8
Active not recruiting
8
Withdrawn
2
Not yet recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Neoplasms
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
86
Bevacizumab
66
Capecitabine
65
Fluorouracil
48
tislelizumab
41
Gemcitabine
40
Drug Therapy
39
Leucovorin
38
sintilimab
35
Irinotecan
34
lenvatinib
27
Cisplatin
27
HMPL-013
25
S 1 (combination)
23
camrelizumab
22
Immune Checkpoint Inhibitors
21
irinotecan sucrosofate
20
apatinib
20
Surgical Procedures, Operative
20
Radiotherapy
20
Injections
20
130-nm albumin-bound paclitaxel
20
toripalimab
19
Paclitaxel
18
Folfox protocol
17
pembrolizumab
15
Immunotherapy
15
Cetuximab
15
Specimen Handling
14
regorafenib
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
folfirinox
×
Gastrointestinal
×
Clear all
NCT07340567
2026-01-14
CIRCULATEIII
UNICANCER
Phase 3
Not yet recruiting
2,450 enrolled
NCT07208539
2025-10-06
ZSPAC-14
Shanghai Zhongshan Hospital
Phase 2
Not yet recruiting
77 enrolled